Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 188,000 | 76,000 | 61,000 |
| General And Administrative Expense | 188,000 | 76,000 | 61,000 |
| Operating Expense | 188,000 | 76,000 | 61,000 |
| Operating Income | -188,000 | -76,000 | -61,000 |
| EBIT | -188,000 | -76,000 | -61,000 |
| Interest Income | 110,000 | 139,000 | 146,000 |
| Interest Income Non Operating | 110,000 | 139,000 | 146,000 |
| Net Interest Income | 105,000 | 134,000 | 141,000 |
| Other Income Expense | -- | -1,000 | -- |
| Special Income Charges | 0.00 | -- | 0.00 |
| Gain On Sale Of Security | -- | -1,000 | -- |
| Pretax Income | -83,000 | 57,000 | 80,000 |
| Tax Provision | 3,000 | 3,000 | 3,000 |
| Tax Effect Of Unusual Items | 0.00 | -52.63 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -86,000 | 54,000 | 77,000 |
| Net Income From Continuing Operation Net Minority Interest | -86,000 | 54,000 | 77,000 |
| Net Income Including Noncontrolling Interests | -86,000 | 54,000 | 77,000 |
| Net Income Common Stockholders | -86,000 | 54,000 | 77,000 |
| Net Income | -86,000 | 54,000 | 77,000 |
| EBITDA | -188,000 | -76,000 | -61,000 |
| Normalized EBITDA | -188,000 | -75,000 | -61,000 |
| Basic EPS | -0.00 | -- | 0.00 |
| Diluted EPS | -0.00 | -- | 0.00 |
| Basic Average Shares | 47.8M | -- | 47.8M |
| Diluted Average Shares | 47.8M | -- | 47.8M |
| Total Unusual Items | 0.00 | -1,000 | 0.00 |
| Total Unusual Items Excluding Goodwill | 0.00 | -1,000 | 0.00 |
| Tax Rate For Calcs | 0.15 | 0.05 | 0.04 |
| Normalized Income | -86,000 | 54,947 | 77,000 |
| Diluted NI Availto Com Stockholders | -86,000 | 54,000 | 77,000 |
| Impairment Of Capital Assets | 0.00 | -- | 0.00 |
| Net Income Continuous Operations | -86,000 | 54,000 | 77,000 |
| Net Non Operating Interest Income Expense | 105,000 | 134,000 | 141,000 |
| Other Gand A | 188,000 | 76,000 | 61,000 |
| Total Expenses | 188,000 | 76,000 | 61,000 |
| Total Other Finance Cost | 5,000 | 5,000 | 5,000 |
| Line Item | Q3 2025Sep 30, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|
| Cash And Cash Equivalents | 10.8M | 11.9M | -- |
| Cash Cash Equivalents And Short Term Investments | 10.8M | 11.9M | -- |
| Cash Financial | 10.8M | 11.9M | -- |
| Receivables | 53,000 | 0.00 | -- |
| Prepaid Assets | -- | 52,000 | -- |
| Current Assets | 10.9M | 11.9M | -- |
| Net PPE | 70.1M | 35.4M | -- |
| Total Non Current Assets | 70.1M | 35.4M | -- |
| Total Assets | 81.0M | 47.4M | -- |
| Accounts Payable | 1.5M | 956,000 | -- |
| Payables | 1.5M | 990,000 | -- |
| Payables And Accrued Expenses | 1.5M | 990,000 | -- |
| Current Liabilities | 1.5M | 990,000 | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | -- |
| Total Liabilities Net Minority Interest | 1.5M | 990,000 | -- |
| Common Stock | 56.8M | 56.8M | -- |
| Capital Stock | 56.8M | 56.8M | -- |
| Retained Earnings | 42.1M | 10.3M | -- |
| Gains Losses Not Affecting Retained Earnings | -19.4M | -20.8M | -- |
| Common Stock Equity | 79.5M | 46.4M | -- |
| Stockholders Equity | 79.5M | 46.4M | -- |
| Total Equity Gross Minority Interest | 79.5M | 46.4M | -- |
| Total Capitalization | 79.5M | 46.4M | -- |
| Net Tangible Assets | 79.5M | 46.4M | -- |
| Tangible Book Value | 79.5M | 46.4M | -- |
| Working Capital | 9.4M | 11.0M | -- |
| Invested Capital | 79.5M | 46.4M | -- |
| Share Issued | 47.8M | 47.8M | -- |
| Ordinary Shares Number | 47.8M | 47.8M | -- |
| Duefrom Related Parties Current | -- | 0.00 | -- |
| Foreign Currency Translation Adjustments | -19.4M | -20.8M | -- |
| Income Tax Payable | 5,000 | 11,000 | -- |
| Other Payable | 10,000 | 10,000 | -- |
| Total Tax Payable | 19,000 | 24,000 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|
| Operating Cash Flow | -- | 214,000 | -- |
| Cash Flow From Continuing Operating Activities | -- | 214,000 | -- |
| Deferred Tax | -- | 3,000 | -- |
| Deferred Income Tax | -- | 3,000 | -- |
| Change In Working Capital | -- | 138,000 | -- |
| Change In Receivables | -- | 20,000 | -- |
| Change In Payables And Accrued Expense | -- | 118,000 | -- |
| Change In Payable | -- | 118,000 | -- |
| Other Non Cash Items | -- | 5,000 | -- |
| Investing Cash Flow | -- | -244,000 | -- |
| Cash Flow From Continuing Investing Activities | -- | -244,000 | -- |
| Changes In Cash | -- | -30,000 | -- |
| Beginning Cash Position | -- | 11.9M | -- |
| End Cash Position | -- | 11.9M | -- |
| Free Cash Flow | -- | 214,000 | -- |
| Change In Account Payable | -- | 118,000 | -- |
| Net Income From Continuing Operations | -- | 54,000 | -- |
| Net Other Investing Changes | -- | -244,000 | -- |